Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal

Journal of Infectious Diseases

Volumn 180, Issue 6, 1999, Pages 2056-2059

  Tacket, Carol O ^a   Losonsky, Genevieve ^a   Livio, Sofie ^a   Edelman, Robert ^a   Crabb, Joseph ^b   Freedman, Daniel ^b,c  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b ImmuCell Corporation   (United States)

^c BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE IMMUNOGLOBULIN; ESCHERICHIA COLI ENTEROTOXIN;

ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; HUMAN; HUMAN EXPERIMENT; INFECTION PREVENTION; MILK; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANIMALS; BACTERIAL PROTEINS; CAPSULES; CATTLE; DIARRHEA; DOUBLE-BLIND METHOD; EATING; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FIMBRIAE PROTEINS; HUMANS; IMMUNOGLOBULINS; MILK;

EID: 0032735697     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315157     Document Type: Article

References (13)

1. 1. Gorbach SL, Kean BH, Evans DG, Evans DJ, Bessudo D. Travelers' diarrhea and toxigenic Escherichia coli. N Engl J Med 1975; 292:933-6.
2. 2. Merson MH, Morris GK, Sack DA, et al. Traveler's diarrhea in Mexico: a prospective study of physicians and family members attending a congress. N Engl J Med 1976;294:1299-305.
3. 3. Shore EG, Dean AG, Holik KJ, David BR. Enterotoxin-producing Escherichia coli and diarrheal disease in adult travelers: a prospective study. J Infect Dis 1974;129:577-82.
4. 4. DuPont HL, Olarte J, Evans DG, et al. Comparative susceptibility of Latin American and United States students to enteric pathogens. N Engl J Med 1976;295:1520-1.
5. 5. Donta ST, Wallace RB, Whipp SC, Olarte J. Enterotoxigenic Escherichia coli and diarrheal disease in Mexican children. J Infect Dis 1977;135:482-5.
6. 6. Guerrant RL, Moore RA, Kirschenfeld PM, Sande M. Role of toxigenic and invasive bacteria in acute diarrhea of childhood. N Engl J Med 1975;293: 567-73.
7. 7. Black RE, Merson MH, Rowe B, et al. Enterotoxigenic Escherichia coli diarrhoea: acquired immunity and transmission in an endemic area. Bull WHO 1981;59:263-8.
8. 8. Savarino SJ, Brown FM, Hall E, et al. Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli cholera toxin B subunit vaccine in Egyptian adults. J Infect Dis 1998;177:796-9.
9. 9. Klipstein FA, Engert RF, Houghton RA. Mucosal antibody response in volunteers to immunization with a synthetic peptide of Escherichia coli heat-stable enterotoxin. Infect Immun 1985;50:328-32.
10. 10. Levine MM, Morris JG, Losonsky G, Boedeker E, Rowe B. Fimbriae (pili) adhesins as vaccines. In: Lark D, Normack S, Brent-Uhlin E, eds. Molecular biology of microbial pathogenicity. London: Academic Press, 1986: 143-34.
11. 11. Tacket CO, Losonsky G, Link H, et al. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med 1988;318:1240-3.
12. 12. Freedman DJ, Tacket CO, Delehanty A, Maneval DR, Nataro J, Crabb JH. Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli. J Infect Dis 1998;177:662-7.
13. 13. Tacket CO, Binion SB, Bostwick E, Losonsky G, Roy MJ, Edelman R. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg 1992;47:276-83.